Haematological malignancies in patients with psoriatic arthritis overall and treated with TNF inhibitors: a Nordic cohort study

OBJECTIVES: To evaluate the risk of haematological malignancies in patients with psoriatic arthritis (PsA) overall, and in relation to treatment with tumour necrosis factor inhibitors (TNFi). METHODS: We identified that patients with PsA starting a first TNFi from the clinical rheumatology registers...

Descripción completa

Detalles Bibliográficos
Autores principales: Cordtz, Rene Lindholm, Askling, Johan, Delcoigne, Benedicte, Smedby, Karin E, Baecklund, Eva, Ballegaard, Christine, Isomäki, Pia, Aaltonen, Kalle, Gudbjornsson, Bjorn, Love, Thorvardur Jon, Provan, Sella Aarrestad, Michelsen, Brigitte, Sexton, Joseph, Dreyer, Lene, Hellgren, Karin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Psoriatic Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9791468/
https://www.ncbi.nlm.nih.gov/pubmed/36564101
http://dx.doi.org/10.1136/rmdopen-2022-002776

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9791468/
https://www.ncbi.nlm.nih.gov/pubmed/36564101
http://dx.doi.org/10.1136/rmdopen-2022-002776

Ejemplares similares